Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,7902 USD | -1,22% | +1,18% | -25,45% |
Omzet 2024 * | 1,63 mln. 1,51 mln. | Omzet 2025 * | 13,61 mln. 12,63 mln. | Marktkapitalisatie | 5,79 mln. 5,37 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -16 mln. -14,85 mln. | Nettowinst (verlies) 2025 * | -11 mln. -10,21 mln. | EV/omzet 2024 * | 3,55 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,43 x |
K/w-verhouding 2024 * |
-0,26
x | K/w-verhouding 2025 * |
-0,34
x | Werknemers | 7 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,3% |
Recentste transcriptie over Ensysce Biosciences, Inc.
1 dag | -1,23% | ||
1 week | +1,18% | ||
Lopende maand | -15,25% | ||
1 maand | -13,73% | ||
3 maanden | -23,28% | ||
6 maanden | -41,90% | ||
Lopend jaar | -25,45% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 67 | 01-01-09 | |
David Humphrey
DFI | Director of Finance/CFO | 55 | 01-02-21 |
Jeffrey Millard
COO | Chief Operating Officer | 49 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Martin
BRD | Director/Board Member | 63 | 01-01-20 |
Chief Executive Officer | 67 | 01-01-09 | |
Bob G. Gower
CHM | Chairman | 86 | 01-01-08 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 0,7902 | -1,23% | 125 780 |
27-03-24 | 0,8 | -2,32% | 104 135 |
26-03-24 | 0,819 | +2,57% | 101 539 |
25-03-24 | 0,7985 | -0,06% | 121 497 |
22-03-24 | 0,799 | +2,30% | 65 723 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,45% | 5,79 mln. | |
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
+4,47% | 10,81 mld. |